Trial
NCT00256308
Adjuvant Chemoradiation With Weekly Oxaliplatin in Resected Head and Neck Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of California, Irvine
Collaborators
Sanofi
Condition
Head and Neck Cancer
Intervention
Oxaliplatin
Why stopped
Halted prematurely due to slow accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-05-01